Evaluation of safety and tolerability of Pelargonium sidoides extract EPs®7630 in children (1 to 5 years old) suffering from acute bronchitis

Registry ID

EUCTR2011-002652-14

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Dr. Willmar Schwabe GmbH & Co. KG

Start date

2011-08-17

Completion date

2013-03-25

Last update

2026-08-16

Conditions

• Acute bronchitis

Summary

To evaluate the safety and tolerability of a treatment with EPs® 7630 syrup in comparison to EPs® 7630 solution in patients between 1 and 5 years old suffering from acute bronchitis.

Locations

• , , Germany

Related clinical trials

• Prospective documentation of inpatient anthroposophic therapy approaches in pediatrics – acute bronchitis
• Description of mechanistic processes and detection of novel biomarkers during exacerbation in children and adolescents with bronchial asthma and chronic bronchitis/Wheeze.
• Effects of communication training with the MAAS-Global-D on the antibiotic prescribing for respiratory infections in primary care: a randomised controlled trial
• Susceptibility to respiratory tract infections

View on source registry